Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+3.27%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| 1 |
Biogen
BIIB
|
+$41.1M |
| 2 |
Intuit
INTU
|
+$38.1M |
| 3 |
Ecolab
ECL
|
+$37.8M |
| 4 |
Autodesk
ADSK
|
+$37.6M |
| 5 |
Coca-Cola
KO
|
+$36.5M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$40.4M |
| 3 |
EOG Resources
EOG
|
+$33.8M |
| 4 |
Microsoft
MSFT
|
+$31.4M |
| 5 |
Ford
F
|
+$30.2M |
Sector Composition
| 1 | Technology | 18.64% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.44% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Shore Bancshares
SHBI
$567M
| $236K | ﹤0.01% |
14,436
+3,750
| +35% | +$61.3K |
|
|
AVP
852
DELISTED
Avon Products, Inc.
AVP
| $235K | ﹤0.01% |
60,600
-1,782,689
| -97% | -$6.91M |
|
853
Seres Therapeutics
MCRB
$171M
| $233K | ﹤0.01% |
3,614
-6,205
| -63% | -$400K |
|
|
FPRX
854
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $231K | ﹤0.01% |
38,260
-29,687
| -44% | -$179K |
|
855
Blackbaud
BLKB
$3.33B
| $230K | ﹤0.01% |
2,760
-12,047
| -81% | -$1M |
|
|
PDCE
856
DELISTED
PDC Energy, Inc.
PDCE
| $230K | ﹤0.01% |
+6,380
| New | +$230K |
|
857
Northeast Bank
NBN
$946M
| $228K | ﹤0.01% |
8,258
-5,058
| -38% | -$140K |
|
|
RNET
858
DELISTED
RigNet, Inc.
RNET
| $228K | ﹤0.01% |
+22,594
| New | +$228K |
|
|
CSS
859
DELISTED
CSS Industries, Inc.
CSS
| $226K | ﹤0.01% |
46,366
+3,841
| +9% | +$18.7K |
|
860
Chemung Financial Corp
CHMG
$254M
| $225K | ﹤0.01% |
+4,651
| New | +$225K |
|
861
PTC Therapeutics
PTCT
$4.65B
| $225K | ﹤0.01% |
+5,010
| New | +$225K |
|
|
LEAF
862
DELISTED
Leaf Group Ltd.
LEAF
| $224K | ﹤0.01% |
30,209
-54,285
| -64% | -$403K |
|
863
Aviat Networks
AVNW
$289M
| $223K | ﹤0.01% |
32,494
| – | – |
|
864
Corvus Pharmaceuticals
CRVS
$460M
| $223K | ﹤0.01% |
+59,718
| New | +$223K |
|
|
AE
865
DELISTED
Adams Resources & Energy Inc.
AE
| $221K | ﹤0.01% |
+6,434
| New | +$221K |
|
866
Catalyst Pharmaceutical
CPRX
$2.47B
| $217K | ﹤0.01% |
56,400
+1,500
| +3% | +$5.77K |
|
867
SouthState Bank Corporation
SSB
$10.3B
| $217K | ﹤0.01% |
+2,950
| New | +$217K |
|
868
Amicus Therapeutics
FOLD
$2.44B
| $215K | ﹤0.01% |
+17,200
| New | +$215K |
|
|
DNKN
869
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $215K | ﹤0.01% |
+2,700
| New | +$215K |
|
|
LTC
870
LTC Properties
LTC
$1.68B
| $213K | ﹤0.01% |
4,660
| – | – |
|
871
Essex Property Trust
ESS
$17.4B
| $211K | ﹤0.01% |
+724
| New | +$211K |
|
872
Larimar Therapeutics
LRMR
$337M
| $211K | ﹤0.01% |
14,795
+9,217
| +165% | +$131K |
|
|
ARC
873
DELISTED
ARC Document Solutions, Inc.
ARC
| $210K | ﹤0.01% |
102,888
+9,798
| +11% | +$20K |
|
874
Northrim BanCorp
NRIM
$508M
| $208K | ﹤0.01% |
5,826
-12,350
| -68% | -$441K |
|
|
MACK
875
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $208K | ﹤0.01% |
43,772
+12,887
| +42% | +$61.2K |
|